An update on the diagnostics of celiac disease

International Reviews of Immunology

Volumn 30, Issue 4, 2011, Pages 185-196

  Lindfors, Katri ^a   Koskinen, Outi ^a   Kaukinen, Katri ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Antibody; Celiac disease; Gluten; Transglutaminase 2; Villous atrophy

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; ENDOMYSIUM ANTIBODY; GLIADIN ANTIBODY; HLA ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; RECOMBINANT ANTIGEN;

ALLERGY; ARTICLE; ATAXIA; CELIAC DISEASE; DERMATITIS HERPETIFORMIS; DISEASE ASSOCIATION; DISEASE COURSE; ENTERITIS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; HISTOLOGY; HUMAN; HYPERPLASIA; IMMUNOFLUORESCENCE; INTESTINE BIOPSY; INTESTINE VILLUS ATROPHY; POLYNEUROPATHY; PRIORITY JOURNAL; PSORIASIS; RHEUMATOID ARTHRITIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; UMBILICAL CORD;

ANIMALS; AUTOANTIBODIES; BIOLOGICAL MARKERS; CELIAC DISEASE; EARLY DIAGNOSIS; GENETIC TESTING; GLIADIN; HLA ANTIGENS; HUMANS; HYPERPLASIA; INDIVIDUALIZED MEDICINE; INTESTINAL MUCOSA; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 79960785032     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.3109/08830185.2011.595854     Document Type: Article

References (107)

1. Walker-Smith JA, Guandalini S, Schmitz J, et al. Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child. 1990;65:909-911. (Pubitemid 20232920)
2. MäkiM, Kallonen K, LähdeahoML, Visakorpi JK. Changing pattern of childhood coeliac disease in Finland. Acta Paediatr Scand. 1988;77:408-412.
3. Rampertab SD, Pooran N, Brar P, et al. Trends in the presentation of celiac disease. Am J Med. 2006;119:355.e9-e14.
4. Collin P, Huhtala H, Virta L, et al. Diagnosis of celiac disease in clinical practice: physician's alertness to the condition essential. J Clin Gastroenterol. 2007;41:152-156. (Pubitemid 46148656)
5. Collin P, Kaukinen K, Välimäki M, Salmi J. Endocrinological disorders and celiac disease. Endocr Rev. 2002;23:464-483.
6. MäkiM, Holm K, Lipsanen V, et al. Serologicalmarkers and HLA genes among healthy first-degree relatives of patients with coeliac disease. Lancet. 1991;338:1350-1353.
7. MäkiM,Mustalahti K, Kokkonen J, et al. Prevalence of celiac disease among children in Finland. N Engl JMed. 2003;348:2517-2524. (Pubitemid 36706539)
8. Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a largemulticenter study. Arch InternMed. 2003;163:286-292. (Pubitemid 36183856)
9. Lohi S,Mustalahti K, Kaukinen K, et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther. 2007;26:1217-1225. (Pubitemid 47620425)
10. Mustalahti K, Catassi C, Reunanen A, et al.The prevalence of celiac disease in Europe: results of a centralized, internationalmass screening project. AnnMed. 2010;42:587-595.
11. Rubio-Tapia A, Kyle RA, Kaplan EL, et al. Increased prevalence andmortality in undiagnosed celiac disease. Gastroenterology. 2009;137:88-93.
12. Vilppula A, Kaukinen K, Luostarinen L, et al. Increasing prevalence and high incidence of celiac disease in elderly people: a population-based study. BMC Gastroenterol. 2009;9:49.
13. West J, Logan RF,Hill PG, et al. Seroprevalence, correlates, and characteristics of undetected celiac disease in England. Gut. 2003;52:960-965. (Pubitemid 36765286)
14. Catassi C, Cellier C, Cerf-Bensussan N, et al. When is a coeliac a coeliac? Report of a working group of the United European Gastroenterology Week in Amsterdam, 2001. Eur J Gastroenterol Hepatol. 2001;13:1123-1128.
15. Rostom A, Dube C, Cranney A, et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology. 2005;128 (Suppl):S38-S46. (Pubitemid 40460820)
16. SternM;Working Group on Serologic Screening for Celiac Disease. Comparative evaluation of serologic tests for celiac disease: a European initiative toward standardization. J Pediatr Gastroenterol Nutr. 2000;31:513-519.
17. Collin P, Kaukinen K, Vogelsang H, et al. Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol. 2005;17:85-91. (Pubitemid 40136613)
18. Volta U,Granito A, Fiorini E, et al. Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up. Dig Dis Sci. 2008;53:1582-1588.
19. Sulkanen S,Halttunen T, Laurila K, et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology. 1998;115:1322-1328. (Pubitemid 28545980)
20. Rostami K, Kerckhaert J, Tiemessen R, et al. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol. 1999;94:888-894. (Pubitemid 29173597)
21. Salmi TT, Collin P,Korponay-Szabó IR, et al. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits. Gut. 2006;55:1746-1753. (Pubitemid 44893572)
22. Maglio M, Tosco A, Paparo F, et al. Serum and intestinal celiac disease-associated antibodies in childrenwith celiac disease younger than 2 years of age. J PediatrGastroenterolNutr. 2010;50:43-48.
23. Abrams JA,Diamond B, RotterdamH, Green PH. Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy. Dig Dis Sci. 2004;49:546-550. (Pubitemid 38992539)
24. Salmi TT, Collin P, Järvinen O, et al. Immunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming coeliac disease. Aliment Pharmacol Ther. 2006;24:541-552. (Pubitemid 44051331)
25. Kurppa K, Collin P, Viljamaa M, et al. Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study. Gastroenterology. 2009;136:816-823.
26. Kurppa K, Ashorn M, Iltanen S, et al. Celiac disease without villous atrophy in children: a prospective study. J Pediatr. 2010;157:373-380.
27. DieterichW, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. NatMed. 1997;3:797-801. (Pubitemid 27298728)
28. Park D, Choi SS,HaKS. Transglutaminase 2: amulti-functional protein inmultiple subcellular compartments. Amino Acids. 2010;39:619-631.
29. Lewis NR, Scott BB. Systematic review: the use of serology to exclude or diagnose coeliac disease (a comparison of the endomysial and tissue transglutaminase antibody tests).Aliment Pharmacol Ther. 2006;24:47-54. (Pubitemid 43894004)
30. Wong RC,Wilson RJ, Steele RH, et al. A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kits. J Clin Pathol. 2002;55:488-494. (Pubitemid 34779298)
31. Raivio T, Korponay-Szabó IR, Paajanen T, et al. Comparison of a novel whole blood transglutaminase-based ELISA with a whole blood rapid antibody test and established conventional serological celiac disease assays. J Pediatr Gastroenterol Nutr. 2008;47:562-567.
32. Katz KD, Rashtak S, Lahr BD, et al. Screening for celiac disease in a North American population: sequential serology and gastrointestinal symptoms. Am J Gastroenterol. 2011;106:1333-1339.
33. Sulkanen S,Collin P, Laurila K,MäkiM. IgA- and IgG-class antihuman umbilical cord antibody tests in adult coeliac disease. Scand J Gastroenterol. 1998;33:251-254. (Pubitemid 28156913)
34. Korponay-Szabó IR, Laurila K, Szondy Z, et al.Missing endomysial and reticulin binding of celiac antibodies in transglutaminase 2 knockout tissues. Gut. 2003;52:199-204. (Pubitemid 36115059)
35. Van Meensel B, Hiele M, Hoffman I, et al. Diagnostic accuracy of ten second-generation (human) tissue transglutaminase antibody assays in celiac disease. Clin Chem. 2004;50:2125-2135. (Pubitemid 39425851)
36. Reeves GE, Squance ML, Duggan AE, et al. Diagnostic accuracy of coeliac serological tests: a prospective study. Eur J Gastroenterol Hepatol. 2006;18:493-501. (Pubitemid 43832747)
37. Pinkas DM, Strop P, Brunger AT, Khosla C. Transglutaminase 2 undergoes a large conformational change upon activation. PLoS Biol. 2007;5:e327.
38. Lindfors K, Koskinen O, Kurppa K, et al. Serodiagnostic assays for celiac disease based on the open or closed conformation of the autoantigen, transglutaminase 2. J Clin Immunol. 2011;31:436-442.
39. Naiyer AJ, Hernandez L, Ciaccio EJ, et al. Comparison of commercially available serologic kits for the detection of celiac disease. J Clin Gastroenterol. 2009;43:225-232.
40. Sugai E,MorenoML,HwangHJ, et al. Celiac disease serology in patientswith different pretest probabilities: is biopsy avoidable?World J Gastroenterol. 2010;16:3144-3152.
41. Korponay-Szabo IR, Szabados K, Pusztai J, et al. Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study. BMJ. 2007;335:1244-1247.
42. Baviera LC, Aliaga ED,Ortigosa L, et al. Celiac disease screening by immunochromatographic visual assays: results of amulticenter study. J Pediatr Gastroenterol Nutr. 2007;45:546-550. (Pubitemid 350307139)
43. Ferre-López S, Ribes-Koninckx C, Genzor C, et al. Immunochromatographic sticks for tissue transglutaminase and antigliadin antibody screening in celiac disease. Clin Gastroenterol Hepatol. 2004;2:480-484. (Pubitemid 38698363)
44. Dulay S, Lozano-Śanchez P, Iwuoha E, et al. Electrochemical detection of celiac disease-related anti-tissue transglutaminase antibodies using thiol based surface chemistry. Biosens Bioelectron. doi:10.1016/j.bios. 2011.02.045.
45. Raivio T, Kaukinen K, Nemes E, et al. Self transglutaminase-based rapid coeliac disease antibody detection by a lateral flow method. Aliment Pharmacol Ther. 2006;24:147-154. (Pubitemid 43894015)
46. Alarida K, Harown J, Ahmaida A, et al. Coeliac disease in Libyan children: a screening study based on the rapid determination of anti-transglutaminase antibodies. Dig Liver Dis. doi:10.1016/j.dld.2011.01.002
47. Ruuskanen A, Kaukinen K, Collin P, et al. Positive serumantigliadin antibodies without celiac disease in the elderly population: does itmatter? Scand J Gastroenterol. 2010;45:1197-1202.
48. LaassMW, Koch T, Lösel A, et al. Longitudinal follow-up examination of antigliadin antibody positive children and adults. Eur J Gastroenterol Hepatol. 2006;18:503-506. (Pubitemid 43832748)
49. Kaukinen K, Turjanmaa K, Mäki M, et al. Intolerance to cereals is not specific for coeliac disease. Scand J Gastroenterol. 2000;35:942-946.
50. Michaelsson G, Gerden B, Hagforsen E, et al. Psoriasis patients with antibodies to gliadin can be improved by a gluten-free diet. Br J Dermatol. 2000;142:44-51. (Pubitemid 30074469)
51. Tursi A, Giorgetti GM, Brandimarte G, Elisei W. High prevalence of celiac disease among patients affected by Crohn's disease. Inflamm Bowel Dis. 2005;11:662-666. (Pubitemid 40961080)
52. Hadjivassiliou M, Sanders DS, Grünewald RA, et al. Gluten sensitivity: from gut to brain. Lancet Neurol. 2010;9:318-330.
53. Sapone A, Lammers KM, Casolaro V, et al. Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity. BMC Med. 2011;9:23
54. Simell S, Hoppu S, Hekkala A, et al. Fate of five celiac disease-associated antibodies during normal diet in genetically at-risk childrenobserved frombirth in anatural history study.AmJGastroenterol. 2007;102:2026-2035. (Pubitemid 47301530)
55. Molberg O, Mcadam SN, Körner R, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med. 1998;4: 713-717. (Pubitemid 28274673)
56. van deWal Y, Kooy Y, van Veelen P, et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol. 1998;161:1585-1588. (Pubitemid 28387571)
57. Prince HE. Evaluation of the INOVA diagnostics enzyme-linked immunosorbent assay kits for measuring serum immunoglobulin G (IgG) and IgA to deamidated gliadin peptides. Clin Vaccine Immunol. 2006;13:150-151.
58. Kaukinen K, Collin P, Laurila K, et al. Resurrection of gliadin antibodies in coeliac disease: deamidated gliadin peptide antibody test provides additional diagnostic benefit. Scand J Gastroenterol. 2007;42:1428-1433. (Pubitemid 350125555)
59. Lewis NR, Scott BB. Meta-analysis: deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for coeliac disease. Aliment Pharmacol Ther. 2010;31:73-81.
60. Villalta D, Tonutti E, Prause C, et al. IgG antibodies against deamidated gliadin peptides for diagnosis of celiac disease in patients with IgA deficiency. Clin Chem. 2010;56:464-468.
61. Aleanzi M, Demonte AM, Esper C, Garcilazo S, Waggener M. Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides. Clin Chem. 2001;47:2023-2028. (Pubitemid 33010719)
62. Sugai E, Vázquez H,Nachman F, et al. Accuracy of testing for antibodies to synthetic gliadin-related peptides in celiac disease. Clin Gastroenterol Hepatol. 2006;4:1112-1117. (Pubitemid 44311641)
63. Karell K, Louka AS,Moodie SJ, et al.HLA types in celiac disease patients not carrying theDQA105- DQB102 (DQ2) heterodimer: results fromthe European Genetics Cluster on Celiac Disease. Hum Immunol. 2003;64:469-477. (Pubitemid 36373778)
64. Kaukinen K, Partanen J, Mäki M, Collin P. HLA-DQ typing in the diagnosis of celiac disease. Am J Gastroenterol. 2002;97:695-699. (Pubitemid 34245900)
65. Dubois PC, Trynka G, Franke L, et al.Multiple common variants for celiac disease influencing immune gene expression. Nat Genet. 2010;42:295-302.
66. Auricchio R, Granata V, Borrelli M, Troncone R; Italian Society for Pediatric GastroenterologyHepatology andNutrition (SIGENP).Italian paediatricians' approach to coeliac disease diagnosis. J Pediatr Gastroenterol Nutr. 2009;49:374-376.
67. Stenhammar L, Högberg L, Danielsson L, et al. How do Swedish paediatric clinics diagnose celiac disease? Results of a nationwide questionnaire study. Acta Paediatr. 2006;95:1495-1497. (Pubitemid 44643568)
68. Collin P, Reunala T. Recognition and management of the cutaneous manifestations of celiac disease: a guide for dermatologists. Am J Clin Dermatol. 2003;4:13-20. (Pubitemid 36078536)
69. Freeman HJ. Adult celiac disease and the severe "flat" small bowe l biopsy lesion. Dig Dis Sci. 2004;49:535-545. (Pubitemid 38992538)
70. Murray JA, Rubio-Tapia A, Van Dyke CT, et al.Mucosal atrophy in celiac disease: extent of involvement, correlationwith clinical presentation, and response to treatment. ClinGastroenterolHepatol. 2008;6:186-193.
71. Weir DC, Glickman JN, Roiff T, et al. V ariability of histopathological changes in childhood celiac disease. Am J Gastroenterol. 2010;105:207-212.
72. Ravelli A, Villanacci V,Monfredini C, et al. How patchy is patchy villous atrophy? Distribution pattern of histological lesions in the duodenum of children with celiac disease. Am J Gastroenterol. 2010;105:2103-2110.
73. Bonamico M,Thanasi E, Mariani P, et al. Duodenal bulb biopsies in celiac disease: a multicenter study. J Pediatr Gastroenterol Nutr. 2008;47:618-622.
74. Kurppa K, Koskinen O, Collin P, et al. Changing phenotype o f celiac disease after long-termgluten exposure. J Pediatr Gastroenterol Nutr. 2008;47:500-503.
75. Matysiak-Budnik T, Malamut G, de Serre NP, et al. Long-term follow-up of 61 coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet. Gut. 2007;56: 1379-1386. (Pubitemid 47517831)
76. Pais WP, Duerksen DR, Pettigrew NM, Bernstein CN. How many duodenal biopsy specimens are required tomake a diagnosis of celiac disease? Gastrointest Endosc. 2008;67:1082-1087.
77. Rashid M,MacDonald A. Importance of duodenal bulb biopsies in children for diagnosis of celiac disease in clinical practice. BMC Gastroenterol. 2009;9:78.
78. Yantiss RK, Odze RD. Optimal approach to obtaining mucosal biopsies for assessment of inflammatory disorders of the gastrointestinal tract. Am J Gastroenterol. 2009;104:774-783.
79. Pinto Sanchez MI, Smecuol E, Vasquez H, et al. Very high rate of misdiagnosis of celiac disease in clinical practise. Acta Gastroenterol Latinoam. 2009;39:250-253.
80. Troncone R, Ivarsson A, Szajewska H, et al. Review article: future research on coeliac disease-a position report fromthe Europeanmultistakeholder platformon coeliac disease (CDEUSSA).Aliment Pharmacol Ther. 2008;27:1030-1043. (Pubitemid 351614884)
81. Salmi TT, Collin P, Reunala T, et al. Diagnostic methods beyond conventional histology in celiac disease diagnosis. Dig Liver Dis. 2010;42:28-32.
82. Koskinen O, Collin P, Lindfors K, et al.Usefulness of small-bowelmucosal transglutaminase-2 specific autoantibody deposits in the diagnosis and follow-up of celiac disease. J Clin Gastroenterol. 2010;44:483-488.
83. Paparo F, Petrone E, Tosco A, et al. Clinical, HLA, and small bowel immunohistochemical features of children with positive serum antiendomysium antibodies and architecturally normal small intestinalmucosa. Am J Gastroenterol. 2005;100:2294-2298.
84. Aziz I,EvansKE,Hopper AD, et al.Aprospective study into the aetiology of lymphocyticduodenosis. Aliment Pharmacol Ther. 2010;32:1392-1397.
85. Vande Voort JL,Murray JA, Lahr BD, et al. Lymphocytic duodenosis and the spectrum of celiac disease. Am J Gastroenterol. 2009;104:142-148.
86. Kokkonen J, Holm K, Karttunen TJ, Mäki M. Children with untreated food allergy express a relative increment in the density of duodenal gammadelta+ T cells. Scand J Gastroenterol. 2000;35:1137-1142.
87. Järvinen TT, Collin P, Rasmussen M, et al. Villous tip intraepithelial lymphocytes as markers of early-stage coeliac disease. Scand J Gastroenterol. 2004;39:428-433. (Pubitemid 38626621)
88. Goldstein NS, Underhill J. Morphologic features suggestive of gluten sensitivity in architecturally normal duodenal biopsy specimens. AmJ Clin Pathol. 2001;116:63-71. (Pubitemid 32601128)
89. Pellegrino S, Villanacci V, Sansotta N, et al. Redefining the intraepithelial lymphocytes threshold to diagnose gluten sensitivity in patients with architecturally normal duodenal histology. Aliment Pharmacol Ther. 2011;33:697-706.
90. Marzari R, Sblattero D, Florian F, et al.Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease. J Immunol. 2001;166:4170-4176. (Pubitemid 32224950)
91. Korponay-Szabó IR, Halttunen T, Szalai Z, et al. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut. 2004;53:641-648. (Pubitemid 38561440)
92. Maglio M, Tosco A, Auricchio R, et al. Intestinal deposits of anti-tissue transglutaminase IgA in childhood celiac disease. Dig Liver Dis. doi:10.1016/j.dld.2011.01.015.
93. Tosco A, Salvati VM, Auricchio R, et al. Natural history of potential celiac disease in children. Clin Gastroenterol Hepatol. 2011;9:320-325.
94. Catassi C, Fasano A. Celiac disease diagnosis: simple rules are better than complicated algorithms. Am JMed. 2010;123:691-693.
95. Kaukinen K, Collin P,MäkiM. Latent coeliac disease or coeliac disease beyond villous atrophy?Gut. 2007;56:1339-1340. (Pubitemid 47517820)
96. Barker CC, Mitton C, Jevon G, Mock T. Can tissue transglutaminase antibody titers replace small-bowel biopsy to diagnose celiac disease in select pediatric populations? Pediatrics. 2005;115:1341-1346. (Pubitemid 43843241)
97. Hill PG, Holmes GK. Coeliac disease: a biopsy is not always necessary for diagnosis. Aliment Pharmacol Ther. 2008;27:572-577. (Pubitemid 351316782)
98. Donaldson MR, Firth SD, Wimpee H,, et al. Correlation of duodenal histology with tissue transglutaminase and endomysial antibody levels in pediatric celiac disease. Clin Gastroenterol Hepatol. 2007;5:567-573. (Pubitemid 46660765)
99. Vivas S, Ruiz deMorales JG, Riestra S, et al. Duodenal biopsy may be avoided when high transglutaminase antibody titers are present.World J Gastroenterol. 2009;15:4775-4780.
100. Kurppa K, Collin P, Sievänen H, et al. Gastrointestinal symptoms, quality of life and bone mineral density inmild enteropathic coeliac disease: a prospective clinical trial. Scand J Gastroenterol. 2010;45:305-314.
101. Jain KK. Personalized clinical laboratory diagnostics. Adv Clin Chem. 2009;47:95-119.
102. Juuti-Uusitalo K,MäkiM, Kaukinen K, et al. cDNA microarray analysis of gene expression in celiac disease jejunal biopsy samples. J Autoimmun. 2004;22:249-265. (Pubitemid 38372193)
103. Diosdado B,Wapenaar MC, Franke L, et al. A microarray screen for novel candidate genes in celiac disease pathogenesis. Gut. 2004;53:944-951. (Pubitemid 38824150)
104. Bertini I, Calabró A, De Carli V, et al.Themetabonomic signature of celiac disease. J Proteome Res. 2009;8:170-177.
105. Simula MP, Cannizzaro R, Canzonieri V, et al. PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage.MolMed. 2010;16:199-209.
106. Virta LJ, Kaukinen K, Collin P. Incidence and prevalence of diagnosed coeliac disease in Finland: results of effective case finding in adults. Scand J Gastroenterol. 2009;44:933-938.
107. Evans KE,Malloy AR, Gorard DA. Changing patterns of coeliac serology requests. Aliment Pharmacol Ther. 2009;29:1137-1142.